TSE:LEAF - MedReleaf Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$25.56 +0.56 (+2.24 %)
(As of 05/24/2018 07:48 AM ET)
Previous CloseC$25.00
Today's RangeC$24.69 - C$25.65
52-Week RangeC$6.81 - C$31.25
Volume695,500 shs
Average Volume724,125 shs
Market CapitalizationC$1.91 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About MedReleaf (TSE:LEAF)

MedReleaf logoMedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.

Receive LEAF News and Ratings via Email

Sign-up to receive the latest news and ratings for LEAF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryCannabis
SectorMedical
SymbolTSE:LEAF
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-21.65%
Return on Equity-6.38%
Return on Assets-5.47%

Miscellaneous

EmployeesN/A
Outstanding Shares99,145,000

MedReleaf (TSE:LEAF) Frequently Asked Questions

What is MedReleaf's stock symbol?

MedReleaf trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LEAF."

What price target have analysts set for LEAF?

2 Wall Street analysts have issued 1-year target prices for MedReleaf's stock. Their forecasts range from C$20.00 to C$36.00. On average, they anticipate MedReleaf's share price to reach C$28.75 in the next year. View Analyst Ratings for MedReleaf.

Who are some of MedReleaf's key competitors?

Who are MedReleaf's key executives?

MedReleaf's management team includes the folowing people:
  • Mr. Neil J. Closner, CEO & Director
  • Mr. Igor Gimelshtein, CFO & Corp. Sec.
  • Mr. Donald Courtney, Chief Operating Officer
  • Mr. Angelo Fefekos, Vice-Pres of Clinical Affairs & Quality Compliance
  • Mr. Darren Karasiuk, Vice-Pres of Strategy

Has MedReleaf been receiving favorable news coverage?

Media headlines about LEAF stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MedReleaf earned a news impact score of 0.04 on Accern's scale. They also assigned press coverage about the company an impact score of 46.46 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of MedReleaf?

Shares of LEAF and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is MedReleaf's stock price today?

One share of LEAF stock can currently be purchased for approximately C$25.56.

How big of a company is MedReleaf?

MedReleaf has a market capitalization of C$1.91 billion.


MarketBeat Community Rating for MedReleaf (LEAF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  86 (Vote Underperform)
Total Votes:  169
MarketBeat's community ratings are surveys of what our community members think about MedReleaf and other stocks. Vote "Outperform" if you believe LEAF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LEAF will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MedReleaf (TSE:LEAF) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for MedReleaf in the last 12 months. Their average twelve-month price target is C$28.75, suggesting that the stock has a possible upside of 12.48%. The high price target for LEAF is C$36.00 and the low price target for LEAF is C$20.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.50
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: C$28.75C$28.67C$28.67C$20.00
Price Target Upside: 12.48% upside36.05% upside36.05% upside20.41% upside

MedReleaf (TSE:LEAF) Consensus Price Target History

Price Target History for MedReleaf (TSE:LEAF)

MedReleaf (TSE:LEAF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/15/2018Eight CapitalDowngradeBuy ➝ TenderView Rating Details
5/15/2018CormarkDowngradeBuy ➝ TenderView Rating Details
5/8/2018Beacon SecuritiesReiterated RatingBuyC$29.00View Rating Details
2/14/2018Canaccord GenuityBoost Price TargetBuyC$21.50 ➝ C$30.00View Rating Details
1/8/2018CowenBoost Price TargetC$20.00 ➝ C$36.00View Rating Details
(Data available from 5/24/2016 forward)

Earnings

Dividends

MedReleaf (TSE:LEAF) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

MedReleaf (TSE LEAF) Insider Trading and Institutional Ownership History

Insider Trading History for MedReleaf (TSE:LEAF)

MedReleaf (TSE LEAF) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/13/2018Ray LeachInsiderSell100,000C$19.40C$1,940,000.00
4/6/2018Ray LeachInsiderSell41,500C$15.40C$639,100.00
3/27/2018Eitan PopperInsiderBuy27,500C$18.09C$497,475.00
3/7/2018Ray LeachInsiderSell100,000C$19.75C$1,975,000.00
3/1/2018Ray LeachInsiderSell77,800C$20.04C$1,559,112.00
2/27/2018Ray LeachInsiderSell19,600C$19.00C$372,400.00
2/9/2018Stephen ArbibInsiderSell36,600C$18.01C$659,166.00
2/6/2018Stephen ArbibInsiderSell50,600C$18.00C$910,800.00
1/29/2018Olam Ltd. TikunInsiderSell1,000,000C$22.02C$22,020,000.00
1/25/2018Olam Ltd. TikunInsiderSell28,600C$25.00C$715,000.00
1/23/2018Olam Ltd. TikunInsiderSell29,300C$25.00C$732,500.00
8/24/2017Stephen ArbibInsiderSell100C$8.10C$810.00
8/23/2017Stephen ArbibInsiderSell10,000C$8.10C$81,000.00
6/8/2017Stephen ArbibInsiderBuy800C$7.89C$6,312.00
(Data available from 1/1/2013 forward)

Headlines

MedReleaf (TSE LEAF) News Headlines

Source:
DateHeadline
How My No. 1 Pot Stock Gained 45.8% In 2 Months...How My No. 1 Pot Stock Gained 45.8% In 2 Months...
www.nasdaq.com - May 22 at 7:01 AM
Easiest Double-Digit Profit Youll Ever Make?Easiest Double-Digit Profit You'll Ever Make?
www.fool.ca - May 21 at 3:19 PM
Investors Should Avoid Aurora Cannabis' Acquisition of MedReleaf Like the PlagueInvestors Should Avoid Aurora Cannabis' Acquisition of MedReleaf Like the Plague
finance.yahoo.com - May 18 at 3:20 PM
Aurora to buy MedReleaf for $2.5 billion in pot mega-mergerAurora to buy MedReleaf for $2.5 billion in pot mega-merger
www.cnbc.com - May 16 at 6:54 AM
Weekly Cannabis Report: Aurora/MedReleaf, Canopy, MaricannWeekly Cannabis Report: Aurora/MedReleaf, Canopy, Maricann
seekingalpha.com - May 15 at 3:19 PM
MedReleaf (LEAF) Stock Rating Lowered by CormarkMedReleaf (LEAF) Stock Rating Lowered by Cormark
www.americanbankingnews.com - May 15 at 2:29 PM
MedReleaf (LEAF) Downgraded to Tender at Eight CapitalMedReleaf (LEAF) Downgraded to Tender at Eight Capital
www.americanbankingnews.com - May 15 at 2:29 PM
Aurora to buy MedReleaf for $2.5 billion in biggest ever pot dealAurora to buy MedReleaf for $2.5 billion in biggest ever pot deal
www.reuters.com - May 14 at 3:20 PM
[$$] Aurora Cannabis strikes $2.5bn deal for rival MedReleaf[$$] Aurora Cannabis strikes $2.5bn deal for rival MedReleaf
finance.yahoo.com - May 14 at 3:20 PM
Reefer Merger Madness: Aurora Cannabis, MedReleaf In Record Deal; Canopy Growth Plans NYSE ListingReefer Merger Madness: Aurora Cannabis, MedReleaf In Record Deal; Canopy Growth Plans NYSE Listing
finance.yahoo.com - May 14 at 3:20 PM
Canadas Top Pot Millionaires Just Got Richer With Aurora DealCanada's Top Pot Millionaires Just Got Richer With Aurora Deal
finance.yahoo.com - May 14 at 3:20 PM
Aurora to buy MedReleaf for $2.5 bln in biggest ever pot dealAurora to buy MedReleaf for $2.5 bln in biggest ever pot deal
finance.yahoo.com - May 14 at 3:20 PM
BRIEF-Aurora Cannabis To Acquire MedReleaf in C$3.2 Bln DealBRIEF-Aurora Cannabis To Acquire MedReleaf in C$3.2 Bln Deal
www.reuters.com - May 14 at 7:55 AM
Aurora Cannabis to Buy MedReleaf for $2.5 Billion as Laws EaseAurora Cannabis to Buy MedReleaf for $2.5 Billion as Laws Ease
www.bloomberg.com - May 14 at 7:55 AM
Aurora: Q3 2018, Another Solid Quarter Eclipsed By M&A RumorAurora: Q3 2018, Another Solid Quarter Eclipsed By M&A Rumor
seekingalpha.com - May 10 at 3:19 PM
MedReleaf (LEAF) PT Set at C$29.00 by Beacon SecuritiesMedReleaf (LEAF) PT Set at C$29.00 by Beacon Securities
www.americanbankingnews.com - May 8 at 2:32 PM
Another Marijuana Stock Megadeal: Will Aurora Cannabis Buy MedReleaf?Another Marijuana Stock Megadeal: Will Aurora Cannabis Buy MedReleaf?
finance.yahoo.com - May 6 at 3:18 PM
Are MedReleaf Corp. Owners Looking to Cash Out?Are MedReleaf Corp. Owners Looking to Cash Out?
www.fool.ca - May 3 at 3:19 PM
MedReleaf confirms deal talks with Aurora Cannabis, othersMedReleaf confirms deal talks with Aurora Cannabis, others
www.theglobeandmail.com - May 3 at 3:19 PM
Two top marijuana stock picks from an Echelon Wealth Partners analystTwo top marijuana stock picks from an Echelon Wealth Partners analyst
www.theglobeandmail.com - April 30 at 3:19 PM
Pot Firm Green Organic Increases IPOPot Firm Green Organic Increases IPO
www.bloomberg.com - April 26 at 6:28 AM
Global Cannabis Pioneer Tikun Olam and Ilera Healthcare Announce Pennsylvania Partnership to Deliver Science-Backed Cannabis Products to PA MMJ PatientsGlobal Cannabis Pioneer Tikun Olam and Ilera Healthcare Announce Pennsylvania Partnership to Deliver Science-Backed Cannabis Products to PA MMJ Patients
finance.yahoo.com - April 17 at 10:31 AM
Ray Leach Sells 100,000 Shares of MedReleaf (LEAF) StockRay Leach Sells 100,000 Shares of MedReleaf (LEAF) Stock
www.americanbankingnews.com - April 13 at 7:09 PM
Better Buy to Beat the TSX: Canada Goose Holdings Inc. or MedReleaf Corp.?Better Buy to Beat the TSX: Canada Goose Holdings Inc. or MedReleaf Corp.?
www.fool.ca - April 13 at 3:21 PM
Marijuana firms use creative marketing tactics to skirt strict regulationsMarijuana firms use creative marketing tactics to skirt strict regulations
www.theglobeandmail.com - April 12 at 3:23 PM
MedReleaf completes 164 acre property and 1 million square foot greenhouse acquisitionMedReleaf completes 164 acre property and 1 million square foot greenhouse acquisition
finance.yahoo.com - April 12 at 3:23 PM
Is MedReleaf Corp’s (TSE:LEAF) Balance Sheet A Threat To Its Future?Is MedReleaf Corp’s (TSE:LEAF) Balance Sheet A Threat To Its Future?
finance.yahoo.com - April 11 at 5:34 AM
MedReleaf (LEAF) Insider Sells C$639,100.00 in StockMedReleaf (LEAF) Insider Sells C$639,100.00 in Stock
www.americanbankingnews.com - April 10 at 4:16 PM
This Marijuana Stock Is Working Smarter, Not HarderThis Marijuana Stock Is Working Smarter, Not Harder
www.fool.com - April 10 at 3:16 PM
MedReleaf announces senior leadership team additions bringing depth and experience from the global pharmaceutical industryMedReleaf announces senior leadership team additions bringing depth and experience from the global pharmaceutical industry
finance.yahoo.com - April 6 at 3:23 PM
Marijuana Millionaires Ride Canadas Legalization WaveMarijuana Millionaires Ride Canada's Legalization Wave
www.bloomberg.com - April 5 at 3:20 PM
MedReleaf Launches AltaVie, a Premium Cannabis Brand Designed with the Higher-End, Wellness-Focused Consumer in MindMedReleaf Launches AltaVie, a Premium Cannabis Brand Designed with the Higher-End, Wellness-Focused Consumer in Mind
finance.yahoo.com - April 3 at 7:40 AM
Canaccord Genuity Reiterates C$15.00 Price Target for MedReleaf (LEAF)Canaccord Genuity Reiterates C$15.00 Price Target for MedReleaf (LEAF)
www.americanbankingnews.com - April 1 at 10:52 PM
Marijuana marketing: The race to stand outMarijuana marketing: The race to stand out
www.theglobeandmail.com - March 31 at 6:33 AM
Marijuana Stocks Could Be a BuzzkillMarijuana Stocks Could Be a Buzzkill
www.barrons.com - March 30 at 3:18 PM
MedReleaf (LEAF) Insider Purchases C$497,475.00 in StockMedReleaf (LEAF) Insider Purchases C$497,475.00 in Stock
www.americanbankingnews.com - March 29 at 1:52 PM
Worldwide Spending in the Legal Cannabis Market is Set to GrowWorldwide Spending in the Legal Cannabis Market is Set to Grow
www.bizjournals.com - March 28 at 3:13 PM
MedReleaf signs supply agreement with Cannamedical Pharma GmbH in GermanyMedReleaf signs supply agreement with Cannamedical Pharma GmbH in Germany
finance.yahoo.com - March 19 at 3:22 PM
Data Projects What Cannabis Market Could Look Like Under Full Federal Legalization - PR Newswire (press release)Data Projects What Cannabis Market Could Look Like Under Full Federal Legalization - PR Newswire (press release)
www.prnewswire.com - March 16 at 3:17 PM
Ray Leach Sells 100,000 Shares of MedReleaf Corp (LEAF) StockRay Leach Sells 100,000 Shares of MedReleaf Corp (LEAF) Stock
www.americanbankingnews.com - March 12 at 2:02 PM
5 Marijuana Stocks With the Highest Production Capacity - Motley Fool5 Marijuana Stocks With the Highest Production Capacity - Motley Fool
www.fool.com - March 9 at 3:24 PM
Marijuana Stocks That Do This Will Probably Be the Most Profitable ... - Motley FoolMarijuana Stocks That Do This Will Probably Be the Most Profitable ... - Motley Fool
www.fool.com - March 7 at 5:30 AM
MedReleaf adds the iconic Woodstock brand to its recreational market portfolioMedReleaf adds the iconic Woodstock brand to its recreational market portfolio
finance.yahoo.com - March 6 at 8:26 AM
Ray Leach Sells 19,600 Shares of MedReleaf Corp (LEAF) StockRay Leach Sells 19,600 Shares of MedReleaf Corp (LEAF) Stock
www.americanbankingnews.com - March 4 at 12:10 AM
MedReleaf Corp (LEAF) Insider Sells C$1,559,112.00 in StockMedReleaf Corp (LEAF) Insider Sells C$1,559,112.00 in Stock
www.americanbankingnews.com - March 4 at 12:10 AM
MedReleaf to purchase 164 acre property, including 1 million square feet of existing greenhouse to add an additional 105,000 kg of fully funded capacity outputMedReleaf to purchase 164 acre property, including 1 million square feet of existing greenhouse to add an additional 105,000 kg of fully funded capacity output
finance.yahoo.com - February 26 at 7:15 AM
MedReleaf Corp. Returns to Growth — and Potential Acquisitions - The Motley Fool CanadaMedReleaf Corp. Returns to Growth — and Potential Acquisitions - The Motley Fool Canada
www.fool.ca - February 16 at 3:18 PM
Pot Pharm: Booming Canada weed sector plots next-wave medicinesPot Pharm: Booming Canada weed sector plots next-wave medicines
www.reuters.com - February 16 at 6:31 AM
Pot Pharm - Booming Canada weed sector plots next-wave medicinesPot Pharm - Booming Canada weed sector plots next-wave medicines
finance.yahoo.com - February 16 at 6:31 AM
Recreational marijuana sales in Canada face fresh delaysRecreational marijuana sales in Canada face fresh delays
finance.yahoo.com - February 16 at 6:31 AM

SEC Filings

MedReleaf (TSE:LEAF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

MedReleaf (TSE LEAF) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.